Page last updated: 2024-09-02

1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and corticosterone

1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with corticosterone in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (33.33)18.2507
2000's6 (50.00)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koob, GF; Menzaghi, F; Merlo-Pich, E; Navarro, M; Rivier, J; Rodríguez de Fonseca, F; Rubio, P1
Carrera, MR; Koob, GF; Navarro, M; Rodríguez de Fonseca, F; Weiss, F1
Bar-Joseph, A; Biegon, A; Gallily, R; Mechoulam, R; Ovadia, H; Shohami, E; Waksmann, Y; Weidenfeld, J; Yamin, A1
Göthert, M; Likungu, J; Molderings, GJ1
del Arco, I; Escudero, L; Martín-Calderón, JL; Muñoz, R; Navarro, M; Rodríguez De Fonseca, F; Villanúa, MA1
Beckett, SR; Chapman, V; Finn, DP; Jhaveri, MD; Kendall, DA; Marsden, CA1
Gorzalka, BB; Hill, MN1
Hader, W; Yang, C; Zhang, X1
Diamond, M; Finn, DP; Kelly, JP; Roche, M1
Floresco, SB; Gorzalka, BB; Hill, MN; Hillard, CJ; McLaughlin, RJ; Morrish, AC; Viau, V1
Galea, LA; Gorzalka, BB; Hill, MN; Lee, TT; Wainwright, SR1
He, X; Huang, R; Wang, M; Wang, S; Yang, L; Zhu, R; Zhuang, X1

Other Studies

12 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and corticosterone

ArticleYear
Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 276, Issue:1

    Topics: Animals; Anxiety; Behavior, Animal; Corticosterone; Corticotropin-Releasing Hormone; Defense Mechanisms; Dronabinol; Drug Interactions; Drug Synergism; Male; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Stress, Physiological; Swimming

1996
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.
    Science (New York, N.Y.), 1997, Jun-27, Volume: 276, Issue:5321

    Topics: Amygdala; Animals; Anxiety; Behavior, Animal; Brain; Corticosterone; Corticotropin-Releasing Hormone; Dronabinol; Male; Microdialysis; Piperidines; Proto-Oncogene Proteins c-fos; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Substance Withdrawal Syndrome

1997
Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 283, Issue:2

    Topics: Animals; Blood Pressure; Cell Line; Corticosterone; Dronabinol; Female; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitric Oxide; Rats; Rats, Sprague-Dawley; RNA, Messenger; Shock, Septic; Tumor Necrosis Factor-alpha

1997
Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship.
    Naunyn-Schmiedeberg's archives of pharmacology, 1999, Volume: 360, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Arachidonic Acids; Atrial Function; Corticosterone; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Electrophysiology; Endocannabinoids; Excitatory Amino Acid Agonists; Female; Guanidine; Humans; Imidazoles; Imidazoline Receptors; Ligands; Male; Norepinephrine; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug; Receptors, Presynaptic; Sympathetic Nervous System; Sympathomimetics

1999
Maternal exposure to the synthetic cannabinoid HU-210: effects on the endocrine and immune systems of the adult male offspring.
    Neuroimmunomodulation, 2000, Volume: 7, Issue:1

    Topics: Administration, Oral; Age Factors; Animals; Corticosterone; Dose-Response Relationship, Drug; Drinking; Dronabinol; Excitatory Amino Acid Antagonists; Female; Follicle Stimulating Hormone; Growth Hormone; Immune System; Insulin-Like Growth Factor I; Lactation; Lymphocyte Subsets; Male; Neuroimmunomodulation; Neurosecretory Systems; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Prolactin; Rats; Rats, Wistar; Spleen; Thymus Gland; Weight Gain

2000
Cannabinoids modulate ultrasound-induced aversive responses in rats.
    Psychopharmacology, 2004, Volume: 172, Issue:1

    Topics: Animals; Behavior, Animal; Corticosterone; Dronabinol; Male; Panic; Periaqueductal Gray; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Ultrasonics

2004
Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure.
    Psychoneuroendocrinology, 2006, Volume: 31, Issue:4

    Topics: Amygdala; Animals; Anxiety; Behavior, Animal; Corticosterone; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Emotions; Exploratory Behavior; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Proto-Oncogene Proteins c-fos; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Restraint, Physical; Stress, Psychological

2006
Therapeutic action of cannabinoid on axonal injury induced by peroxynitrite.
    Brain research, 2006, Mar-03, Volume: 1076, Issue:1

    Topics: Adrenalectomy; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Axons; Brain Diseases; Cannabinoids; Corpus Callosum; Corticosterone; Disease Models, Animal; Dronabinol; Drug Therapy, Combination; Enzyme Inhibitors; Immunohistochemistry; Male; Molsidomine; Morpholines; Peroxynitrous Acid; Pyrazoles; Rats; Rats, Wistar

2006
In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids.
    Journal of neuroimmunology, 2006, Volume: 181, Issue:1-2

    Topics: Animals; Camphanes; Corticosterone; Dronabinol; Drug Interactions; Encephalitis; Hypothalamo-Hypophyseal System; Interferon-gamma; Interleukin-10; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Lymphocyte Count; Male; Neuroimmunomodulation; Neuroprotective Agents; Piperidines; Pituitary-Adrenal System; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Tumor Necrosis Factor-alpha

2006
Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:13

    Topics: Amidohydrolases; Amygdala; Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Modulators; Carbamates; Corticosterone; Dronabinol; Drug Interactions; Endocannabinoids; Hypothalamo-Hypophyseal System; Male; Microinjections; Piperidines; Pituitary-Adrenal System; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Restraint, Physical; Signal Transduction; Stress, Psychological

2009
Sex, drugs, and adult neurogenesis: sex-dependent effects of escalating adolescent cannabinoid exposure on adult hippocampal neurogenesis, stress reactivity, and amphetamine sensitization.
    Hippocampus, 2014, Volume: 24, Issue:3

    Topics: Animals; Cannabinoid Receptor Agonists; Corticosterone; Dentate Gyrus; Dextroamphetamine; DNA Replication; Dose-Response Relationship, Drug; Dronabinol; Estrus; Female; Hypothalamo-Hypophyseal System; Injections, Intraperitoneal; Male; Neurogenesis; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Restraint, Physical; Sex Characteristics; Sexual Maturation; Single-Blind Method; Stereotyped Behavior; Stress, Physiological; Stress, Psychological

2014
Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid Nanoparticles.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 42, Issue:6

    Topics: Animals; Antidepressive Agents; Apoptosis; Behavior, Animal; Corticosterone; Curcumin; Depressive Disorder, Major; Disease Models, Animal; Dopamine; Dronabinol; Drug Carriers; Lipids; MAP Kinase Kinase 1; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nanoparticles; PC12 Cells; Rats; Receptor, Cannabinoid, CB1

2017